|
Completion of the study
|
---|
Baseline (n = 87)
|
Normal echogenic response
|
Fatty liver
|
---|
Tocotrienols (n = 43)
|
15/43
|
28/43
|
|
34.9%
|
65.1%
|
Placebo (n = 44)
|
8/44
|
36/44
|
|
18.2%
|
81.8%
|
Tocotrienols vs Placebo
|
P = 0.038
| |
- Drop-out subjects were computed as having an unchanged diagnosis of fatty liver from baseline.
- [Helmert-Pearson’s Chi Square; Numbers’09, GraphPad].